Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania [6]

Journal of Clinical Psychiatry

Volumn 68, Issue 1, 2007, Pages 170-171

  Coric, Vladimir ^a   Kelmendi, Ben ^a   Pittenger, Christopher ^a   Wasylink, Susanne ^a   Bloch, Michael H ^b   Green, Jeff ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; GLUTAMIC ACID; RILUZOLE;

CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INCIDENCE; LETTER; NEUROTRANSMISSION; OBSESSIVE COMPULSIVE DISORDER; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TRICHOTILLOMANIA;

EID: 33846861283     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v68n0123f     Document Type: Letter

References (22)

1. Christenson GA, Pyle RL, Mitchell JE. Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry 1991;52:415-417
2. King RA, Scahill L, Vitulano LA, et al. Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics. J Am Acad Child Adolesc Psychiatry 1995;34:1451-1459;
3. Comment in: J Am Acad Child Adolesc Psychiatry 1999;38:1470-1471
4. Walsh KH, McDougle CJ. Pharmacological strategies for trichotillomania. Expert Opin Pharmacother 2005;6:975-984
5. Hollander E. Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann 1993;23:355-358
6. Christenson GA, Mackenzie TB, Mitchell JE. Characteristics of 60 adult chronic hair-pullers. Am J Psychiatry 1991;148:365-370
7. Lenane MC, Swedo SE, Rapoport JL, et al. Rates of obsessive-compulsive disorder in first degree relatives of patients with trichotillomania: a research note. J Child Psychol Psychiatry 1992;33:925-933
8. Streichenwein SM, Thornby JI. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 1995;152:1192-1196
9. Christenson GA, Mackenzie TB, Mitchell JE, et al. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 1991;148:1566-1571
10. Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair-pulling). N Engl J Med 1989;321:497-501
11. Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 2006;3:69-81
12. Coric V, Taskiran S, Pittenger C, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open label trial. Biol Psychiatry 2005;58:424-428
13. Coric V, Milanovic S, Wasylink S, et al. Beneficial effects of the anti-glutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Psychopharmacology (Berl) 2003;167:210-220
14. Winchel RM, Jones JS, Molcho A, et al. The Psychiatric Institute Trichotillomania Scale (PITS). Psychopharmacol Bull 1992;28:463-476
15. O'Sullivan RL, Keuthen NJ, Hayday CF. The Massachusetts General Hospital (MGH) Hairpulling Scale, 2: reliability and validity. Psychother Psychosom 1995;64:146-148
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
17. Sasso D, Kalanithi P, Trueblood K, et al. Beneficial effects of the glutamate modulating agent riluzole on disordered eating and pathological skin picking behaviors. J Clin Psychopharmacol. In press
18. Pittenger C, Krystal JH, Coric V. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder [letter]. J Clin Psychiatry 2005;66:1492-1493
19. Zarate CA Jr, Payne JL, Quiroz J, et al. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004;161:171-174
20. Zarate CA Jr, Quiroz JA, Singh JB, et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 2005;57:430-432
21. Sanacora G, Rothman DL, Mason G, et al. Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci 2003;1003:292-308
22. Sanacora G, Kendell SF, Fenton L, et al. Riluzole augmentation for treatment-resistant depression [letter]. Am J Psychiatry 2004;161:2132